Stryker Fails To Convince FDA To Exempt Patient-Transport Devices
Executive Summary
The US agency didn’t buy Stryker’s argument in its April petition that there is no data suggesting patient-transport devices have a history of false and misleading claims.
You may also be interested in...
Stryker Seeks Exemption For Patient-Transport Devices
A petition submitted to the US FDA seeks to exempt class II powered patient-transport devices from premarket notification requirements.
Medicare Proposes NTAP For Breakthrough Treatment Of Spinal Condition
US Medicare has granted a new technology add-on payment (NTAP) for an innovative technology designed to treat adult spinal deformity.
First EUA In US For OTC Test To Detect COVID-19, Flu, RSV Granted To Labcorp
Agency issued an emergency use authorization to Labcorp for its OTC that detects COVID-19, flu and respiratory syncytial virus.